Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from Janssen Sciences Ireland UC regarding Topamax (topiramate): Ongoing EU review of potential risk of neurodevelopmental disorders in children exposed in utero
Important Safety Information - Topamax (topiramate)